Benfotiamine: Fat-Soluble B1 for Nerve Health & Blood Sugar Support

What is Benfotiamine?

Benfotiamine is a synthetic, fat-soluble derivative of thiamine (vitamin B1), chemically known as S-benzoylthiamine O-monophosphate. Unlike conventional water-soluble thiamine, benfotiamine is lipophilic—meaning it dissolves in fat rather than water—allowing it to cross cell membranes and the blood-brain barrier more readily and accumulate in nervous tissue.

Benfotiamine is manufactured synthetically by adding a benzoyl group and a phosphate moiety to thiamine, creating a molecule that behaves differently in the body. Once absorbed, it is hydrolyzed to free thiamine and other metabolites that can be utilized by cells. Its primary mechanism of interest centers on reducing the formation and effects of advanced glycation end products (AGEs)—harmful compounds formed when blood glucose binds to proteins—and supporting energy metabolism and neuronal function through cofactor roles in enzyme systems.

Standard dietary thiamine is water-soluble and poorly bioavailable in peripheral tissues, especially at doses above the RDA. Benfotiamine's lipid solubility offers the advantage of better tissue penetration and accumulation in target organs, particularly the peripheral nervous system, without the toxicity risks associated with true fat-soluble vitamins like vitamins A, D, E, and K.

Evidence-based benefits of Benfotiamine

Benfotiamine is studied as a complementary approach for several conditions related to nerve health and metabolic stress, particularly in people with diabetes. Evidence is preliminary in most areas and is not a replacement for blood sugar control or standard medical care.

Diabetic Peripheral Neuropathy

Small clinical trials and observational studies suggest benfotiamine may reduce symptoms of diabetic neuropathy—pain, numbness, and tingling in the extremities—at doses of 300–600 mg daily. The proposed mechanism involves blocking AGE formation and reducing oxidative stress in nerve tissue. A few European RCTs have shown modest benefit on pain scores and neuronal conduction measures, but evidence is not yet robust enough to recommend it as monotherapy. It is best viewed as an adjunctive approach alongside glycemic control.

Reduction of Advanced Glycation End Products (AGEs)

Laboratory and early human studies indicate that benfotiamine can inhibit AGE formation and may help reduce existing AGE accumulation. Since AGEs contribute to vascular stiffness, inflammation, and tissue damage in diabetes and aging, lowering AGE burden is theoretically beneficial. However, translating this to clinical outcome improvement requires larger, longer-term trials.

Nerve Pain and Sensitivity

Some small trials report improvements in subjective nerve pain and thermal sensitivity when benfotiamine is combined with other interventions (e.g., alpha-lipoic acid). The evidence is suggestive rather than conclusive, and individual responses vary widely.

Vascular and Endothelial Function

Preliminary research suggests benfotiamine may support vascular health by reducing AGE-related endothelial dysfunction. This mechanism is plausible but has not been demonstrated convincingly in large human trials.

Energy Metabolism Support

As a thiamine derivative, benfotiamine participates in carbohydrate and branched-chain amino acid metabolism via cofactor roles in pyruvate dehydrogenase and other enzymes. Whether benfotiamine offers advantages over standard B1 for general energy or exercise performance is unclear and not well-studied.

Benfotiamine deficiency and inadequacy

Thiamine (B1) deficiency is rare in developed countries but can occur in populations with poor nutrition, chronic alcohol use, or certain medical conditions (kidney disease, dialysis, hyperemesis gravidarum, bariatric surgery). Classic deficiency causes beriberi, characterized by peripheral neuropathy (wet or dry forms), heart failure, and encephalopathy. Marginal or subclinical thiamine insufficiency may impair energy metabolism and mood but is difficult to diagnose without biochemical testing.

• Chronic heavy alcohol users and those with alcohol use disorder
• People on long-term dialysis or with severe kidney disease
• Patients with hyperemesis gravidarum or post-bariatric surgery
• Those with malabsorption syndromes (celiac disease, Crohn's disease)
• Individuals with hypermetabolic states (hyperthyroidism, persistent fever)
• Populations with persistently inadequate dietary intake of B1-rich foods (thiamine is found in pork, seeds, nuts, whole grains, legumes)

Supplement forms of Benfotiamine, compared

Benfotiamine is supplied as a stand-alone supplement in capsule or tablet form; it is the predominant or only fat-soluble thiamine form available commercially. Standard pharmaceutical thiamine comes as thiamine hydrochloride (water-soluble) or thiamine mononitrate; benfotiamine offers a distinct absorption and tissue-distribution profile and cannot be easily substituted with conventional B1 supplements without potentially losing the intended benefits.

How much Benfotiamine should you take?

Benfotiamine is not an essential nutrient with an RDA; the RDA for total thiamine (all forms) is 1.1 mg/day for adult women and 1.2 mg/day for adult men. For supplemental benfotiamine targeting nerve health and AGE reduction, typical research doses have ranged from 300 to 600 mg daily, usually split into two or three doses.

• General supplementation: 300–600 mg daily, divided into two to three doses
• Diabetic neuropathy studies: typically 300–600 mg daily for 6–12 weeks or longer
• Maintenance or prevention: 150–300 mg daily (evidence-based dosing is limited)
• No established RDA or upper limit (UL) for benfotiamine (as it is not a recognized dietary requirement); conventional thiamine has no established UL due to low toxicity

Benfotiamine can be taken with or without food, though absorption may be optimized with a meal containing fat. Splitting doses throughout the day may improve steady-state tissue levels. Combining benfotiamine with other B vitamins (especially B6, B12, and folate) is common and may provide complementary support for nerve health; consult a clinician if you are on high-dose B vitamin regimens or have kidney disease.

Safety, side effects, and risks

Benfotiamine is generally safe and well-tolerated. Thiamine and its derivatives have no established toxicity even at high doses because they are water- or fat-soluble vitamins that are not stored in the body at dangerous levels (excess water-soluble thiamine is excreted; excess fat-soluble benfotiamine is converted to free thiamine and excreted). Serious adverse events are extremely rare.

Common Side Effects

Side effects are uncommon and usually mild. Occasional reports include minor gastrointestinal upset (nausea, mild diarrhea), headache, or rash. These typically resolve if dosing is reduced or discontinued.

Rare but Serious Concerns

Severe allergic reactions (anaphylaxis) to thiamine derivatives are reported but extremely rare. Anyone with a known allergy to thiamine or benfotiamine should avoid the supplement.

Pregnancy and Lactation

Thiamine is considered essential during pregnancy and lactation, and the RDA is slightly elevated (1.4 mg/day in pregnancy). Limited safety data exist for benfotiamine specifically in these populations; standard thiamine supplementation is the evidence-based approach. Consult an obstetrician before using benfotiamine during pregnancy or lactation.

Important Safety Notes

Talk to your doctor or healthcare provider if you have kidney disease, are on dialysis, have a thiamine allergy, or are pregnant/breastfeeding. Benfotiamine is not a substitute for blood sugar control, exercise, or medical management of diabetes. If you have diabetic neuropathy or other nerve disorders, medical supervision is essential to rule out reversible causes and ensure appropriate treatment.

Drug and nutrient interactions

• Loop and thiazide diuretics: These medications can increase urinary thiamine loss and may elevate the risk of deficiency; higher B1 intake may be warranted. Monitor for signs of inadequate thiamine status.
• Alcohol: Chronic alcohol impairs thiamine absorption and metabolism; people who drink heavily may benefit from thiamine supplementation, but benfotiamine does not compensate for the harmful effects of excess alcohol.
• Phenytoin and other anticonvulsants: Some anticonvulsants may reduce thiamine bioavailability; supplementing with a B-complex vitamin is often recommended alongside these drugs.
• Hemodialysis and peritoneal dialysis: Dialysis removes water-soluble vitamins including thiamine; dialysis patients often require supplementation and should coordinate with their nephrologist.
• Pancreatic enzyme supplements: High-dose lipase may theoretically reduce absorption of lipid-soluble compounds; separate timing by at least 2 hours if taking benfotiamine with digestive enzymes.

For a complete personalized interaction assessment, use our interaction checker or discuss with a pharmacist or physician, especially if you take multiple medications or have chronic kidney disease.

Who might benefit — and who shouldn't self-supplement without guidance

Frequently asked questions

Related ingredients